I47.2

Ventricular tachycardia

Ventricular tachycardia (VT) is a serious cardiac arrhythmia originating from the ventricles, the lower chambers of the heart. It is characterized by a heart rate exceeding 100-120 beats per minute, which is driven by abnormal electrical signals rather than the heart's natural pacemaker (the sinoatrial node). This rapid rhythm prevents the ventricles from filling completely between contractions, significantly reducing the heart's ability to pump oxygenated blood to the rest of the body. VT is often classified as sustained if it lasts longer than 30 seconds or causes hemodynamic collapse, and non-sustained if it resolves spontaneously in a shorter period. It is most commonly associated with structural heart disease, particularly myocardial scarring from previous infarctions, but it can also result from genetic channelopathies or electrolyte disturbances. Without prompt medical intervention, such as cardioversion or anti-arrhythmic therapy, sustained ventricular tachycardia can degenerate into ventricular fibrillation, leading to sudden cardiac death.

Clinical Symptoms

  • Palpitations
  • Lightheadedness
  • Dizziness
  • Syncope (fainting)
  • Shortness of breath (dyspnea)
  • Chest pain (angina)
  • Hypotension
  • Diaphoresis
  • Anxiety
  • Near-syncope
  • Pulselessness
  • Cardiac arrest

Common Causes

  • Coronary artery disease (CAD)
  • Myocardial infarction (previous heart attack)
  • Cardiomyopathy (dilated, hypertrophic, or restrictive)
  • Heart failure
  • Electrolyte imbalances (hypokalemia, hypomagnesemia)
  • Long QT syndrome (congenital or drug-induced)
  • Brugada syndrome
  • Catecholaminergic polymorphic ventricular tachycardia (CPVT)
  • Drug toxicity (e.g., digoxin, certain anti-arrhythmics)
  • Cocaine or methamphetamine use
  • Valvular heart disease

Documentation & Coding Tips

Explicitly distinguish between sustained and non-sustained ventricular tachycardia. Sustained ventricular tachycardia is defined as lasting longer than 30 seconds or requiring intervention due to hemodynamic collapse.

Example: Patient with known ischemic cardiomyopathy and an EF of 25 percent presented with sustained monomorphic ventricular tachycardia documented on 12-lead ECG. The episode lasted 45 seconds before spontaneous conversion but was associated with hypotension (BP 85 over 50) and near-syncope. This episode is coded as I47.29 to represent specified sustained monomorphic VT, contributing to an HCC 96 risk adjustment category.

Billing Focus: The documentation of duration (sustained vs. non-sustained) and hemodynamic stability is essential for establishing medical necessity for higher-level E/M codes or surgical interventions.

Specify the morphology of the ventricular tachycardia, such as monomorphic or polymorphic, and identify if it is related to a specific syndrome like Torsades de Pointes.

Example: Clinical evaluation of telemetry and 12-lead ECG reveals polymorphic ventricular tachycardia with a characteristic twisting around the isoelectric line, consistent with Torsades de Pointes. The patient's QTc was noted to be 520ms. Diagnosis: Torsades de Pointes (I47.21). This specific diagnosis is high-risk and requires immediate magnesium therapy and possible pacing.

Billing Focus: Specific morphology documentation allows for the use of more granular ICD-10-CM codes such as I47.21 instead of the unspecified I47.20.

Always link the ventricular tachycardia to any underlying structural heart disease or metabolic triggers to provide a complete clinical picture.

Example: 65-year-old male with chronic systolic heart failure and CAD presents with an episode of non-sustained monomorphic ventricular tachycardia. The arrhythmia is likely secondary to myocardial scarring from a previous anteroseptal MI (I25.2). Documentation reflects the relationship between the structural damage and the current cardiac rhythm instability (I47.29).

Billing Focus: Linking arrhythmias to underlying conditions supports the medical necessity for complex diagnostic studies like EP mapping (93654).

Document the presence of an implantable cardioverter-defibrillator and its activity, including any delivered shocks or antitachycardia pacing.

Example: Patient presents for follow-up of ICD (Z95.81) for primary prevention of VT. Device interrogation shows three episodes of monomorphic ventricular tachycardia successfully terminated by antitachycardia pacing (ATP). No high-voltage shocks were delivered. Current diagnosis: Recurrent monomorphic ventricular tachycardia (I47.29) effectively managed by ICD.

Billing Focus: ICD interrogation reports and documentation of ATP or shocks provide objective data for billing 93282 (ICD programming) or 93287 (ICD interrogation).

Clearly document the diagnostic criteria used to differentiate ventricular tachycardia from supraventricular tachycardia with aberrancy.

Example: ECG shows a wide-complex tachycardia at a rate of 180 bpm. Analysis shows AV dissociation and the presence of fusion beats, confirming a diagnosis of Ventricular Tachycardia (I47.20) rather than SVT with bundle branch block. Patient remains hemodynamically stable currently.

Billing Focus: Detailed ECG analysis documentation supports the higher complexity of MDM required for 99215 or 99205 levels.

Relevant CPT Codes

Related Diagnoses

Hierarchy